Insights

Event

ACI Drug & Medical Device Litigation Conference 2023

New York, New York

December 6, 2023

On December 6, Dan Troy took part in the panel “FDA in the Crosshairs: What Recent Court Activity and State Litigation Over Mifepristone Means for the Future of Agency Deference” with Sarah Padgitt (Associate General Counsel, Baxter) and Thomas Kurland (Partner, Patterson Belknap).

BRG was a proud sponsor of the conference. Find out more.

BRG Experts

Related Professionals

Dan Troy

Managing Director

Washington, DC